An Xu

490 total citations
12 papers, 302 citations indexed

About

An Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, An Xu has authored 12 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in An Xu's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Mitochondrial Function and Pathology (2 papers). An Xu is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Mitochondrial Function and Pathology (2 papers). An Xu collaborates with scholars based in China. An Xu's co-authors include Wenhao Qin, Hongyang Wang, Jing Fu, Yao Chen, Bibo Wang, Tao Luo, Bo Su, Ning Li, Jinhua Jiang and Juan Li and has published in prestigious journals such as Hepatology, Cancer Letters and Autophagy.

In The Last Decade

An Xu

11 papers receiving 299 citations

Peers

An Xu
An Xu
Citations per year, relative to An Xu An Xu (= 1×) peers Yiming Lei

Countries citing papers authored by An Xu

Since Specialization
Citations

This map shows the geographic impact of An Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Xu more than expected).

Fields of papers citing papers by An Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Xu. The network helps show where An Xu may publish in the future.

Co-authorship network of co-authors of An Xu

This figure shows the co-authorship network connecting the top 25 collaborators of An Xu. A scholar is included among the top collaborators of An Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Xu. An Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Yang, Shuai, Ruru Wang, Lingling Liu, et al.. (2024). RRM1 promotes homologous recombination and radio/chemo-sensitivity via enhancing USP11 and E2F1-mediated RAD51AP1 transcription. Cell Death Discovery. 10(1). 496–496. 2 indexed citations
3.
Xu, An, Chao Sun, Fang Tong, et al.. (2023). LINC00654 confers sorafenib resistance by suppressing ferroptosis via STAT3-mediated transcriptional activation of SLC7A11 in hepatocellular carcinoma. Colloids and Surfaces A Physicochemical and Engineering Aspects. 669. 131458–131458. 6 indexed citations
4.
Gao, Yang, Bin Chen, Ruru Wang, et al.. (2022). Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis. Cell Death Discovery. 8(1). 343–343. 24 indexed citations
5.
Kang, Xiaofeng, Yan Huo, Fuliang He, et al.. (2022). Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma. Frontiers in Oncology. 12. 939605–939605. 37 indexed citations
6.
Zhu, Xiang, An Xu, Nan Huo, et al.. (2020). <p>ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 10515–10523. 7 indexed citations
7.
Xu, An, Jing Fu, Wenhao Qin, et al.. (2018). Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α. Cancer Letters. 442. 40–52. 16 indexed citations
8.
Wang, Bibo, Jing Fu, Ting Yu, et al.. (2017). Contradictory effects of mitochondria‐ and non‐mitochondria‐targeted antioxidants on hepatocarcinogenesis by altering DNA repair in mice. Hepatology. 67(2). 623–635. 29 indexed citations
9.
Li, Ning, Jinhua Jiang, Jing Fu, et al.. (2016). Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 35(1). 140–140. 20 indexed citations
10.
Zhao, Xiaying, Jing Fu, An Xu, et al.. (2015). Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death and Disease. 6(5). e1751–e1751. 43 indexed citations
11.
12.
Liu, Xuelan, An Xu, Yin Dai, Hang Yuan, & Zengliang Yu. (2011). Surface Etching and DNA Damage Induced by Low-Energy Ion Irradiation in Yeast. Plasma Science and Technology. 13(3). 381–384. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026